| About the author: |
O. I. Makedonska, O. S. Voronkova, Yu. S. Voronkova, A. I. Vinnikov |
| Heading |
EXPERIMENTAL MEDICINE |
| Type of article |
Scentific article |
| Annotation |
Changes of microbiocenosis of different biotopes of the human body are known as dysbiosis. For the renovation of the composition of the microbiota, use the bacteriotherapeutic preparations – probiotics. The aim of the research was to study the effectiveness of the use of the mixed suspension of cells of probiotic strains Bacillus subtilis and Bacillus licheniformis for the correction of the composition of the microbiota of the vagina of white laboratory mice, induced by the intravaginal introduction of a biofilm forming strain of Staphylococcus aureus. It was shown that in cases of dysbiosis of genitourinary tract of mice, induced by the intravaginal introduction of a biofilm-forming strain of S. aureus, the use of probiotic microorganisms B. subtilis and B. licheniformis led to the tendency to normalization of the vaginal microbiota. Renovation of vaginal microbiome characterized by the increase of ratio anaerobic to anaerobic bacteria to 1: 71–1: 87 that in fact corresponded to normal index; the decrease of the frequency of determination and quantity of opportunistic bacteria, such as staphylococci and enterobacteria. |
| Tags |
vaginal dysbiosis, microbiota, correction, probiotic, bacilli |
| Bibliography |
- Labinskaia АS, Volina YeH. (Eds.). Rukovodstvo po meditsinskoy mikrobiologii. Kniga 1. Obshchaya i anitarnaya mikrobiologiya. Мoscow, Binom. 2008. 1080 p. [in Russian]
- Abdel Halim RM, Kassem NN, Mahmoud BS. Detection of biofilm producing staphylococci among different clinical isolates and its relation to methicillin susceptibility. Open Access Maced J Med Sci. 2018; 6(8): 1335–1341. doi: 10.3889/oamjms.2018.246.
- Bagnall P, Rizzolo D. Bacterial vaginosis: A practical review. JAAPA. 2017; 12: 15–21. doi: 10.1097/01.JAA.0000526770.60197.fa.
- Bobrova NA, Vazhnichaya EM, Loban GA, Lugovaya LA, Balyuk OYe, Bashtovenko OA. Evaluation of susceptibility of reference strains of microorganisms to the combined action of essential oils and mexidol. World of Medicine and Biology. 2021; 2(76): 173–178. DOI 10.26724/2079-8334-2021-2-76-173-178.
- Dakheel KH, Abdul Rahim R, Neela VK, Al-Obaidi JR, Hun TG, Yusoff K. Methicillin-resistant Staphylococcus aureus biofilms and their influence on bacterial adhesion and cohesion. Biomed Res Int. 2016; 2016: 4708425. doi: 10.1155/2016/4708425.
- Donders GG, Zodzika J, Rezeberga D. Treatment of bacterial vaginosis: what we have and what we miss. Expert Opin. Pharmacother. 2014; 15(5): 645–657. doi: 10.1517/14656566.2014.881800.
- Elshaghabee FMF, Rokana N, Gulhane RD, Sharma C, Panwar H. Bacillus as potential probiotics: status, concerns, and future perspectives. Front Microbiol. 2017; 8: 1490. doi:10.3389/fmicb.2017.01490.
- Gille C, Böer B, Marschal M, Urschitz MS, Heinecke V, Hund V, et al. Effect of probiotics on vaginal health in pregnancy. EFFPRO, a randomized controlled trial. Am. J. Obstet. Gynecol. 2016; 215(5): 608.e1–608.e7. doi: 10.1016/j.ajog.2016.06.021.
- Holt JG, Кrieg NR, Sneath PHA, Staley JT, Williams ST, editors. Bergey’s manual of determinative bacteriology. Baltimore: Williams & Wilkins; 1994. 787 p.
- Khalesi S, Bellissimo N, Vandelanotte C, Williams S, Stanley D, Irwin C. A review of probiotic supplementation in healthy adults: helpful or hype? Eur J Clin Nutr. 2019; 73(1): 24–37. doi: 10.1038/s41430-018-0135-9.
- Kirihara N, Kamitomo M, Tabira T, Hashimoto T, Taniguchi H, Maeda T. Effect of probiotics on perinatal outcome in patients at high risk of preterm birth. J Obstet Gynaecol Res. 2018; 44(2): 241–247. doi: 10.1111/jog.13497.
- Lazarenko L, Babenko L, Shynkarenko-Sichel L, Pidgorskyi V, Mokrozub V, Voronkova O, et al. Antagonistic Action of Lactobacilli and Bifidobacteria in Relation to Staphylococcus aureus and Their Influence on the Immune Response in Cases of Intravaginal Staphylococcosis in Mice Probiotics Antimicrob Proteins. 2012; 4(2): 78–89. doi: 10.1007/s12602-012-9093-z.
- Lefevre M, Racedo SM, Denayrolles M, Ripert G, Desfougeres T, Lobach AR, et al. Safety assessment of Bacillus subtilis CU1 for use as a probiotic in humans. Regul Toxicol Pharmacol. 2017; 83: 54–65. doi: 10.1016/j.yrtph.2016.11.010.
- Uruén C, Chopo-Escuin G, Tommassen J, Mainar-Jaime RC, Arenas J. Biofilms as Promoters of Bacterial Antibiotic Resistance and Tolerance. Antibiotics (Basel). 2020; 10(1): 3. doi:10.3390/antibiotics10010003.
- Wolcott R, Costerton JW, Raoult D, Cutler SJ. The polymicrobial nature of biofilm infection. Clinical Microbiology and Infection. 2013; 19(2): 107–112. doi: 10.1111/j.1469-0691.2012.04001.x.
|
| Publication of the article |
«World of Medicine and Biology» №1(79), 2022 year, 209-213 pages, index UDK 579.61:579.861.2: 615.331 |
| DOI |
10.26724/2079-8334-2022-1-79-209-213 |
